Russo A - Search Results

1

Conquests and perspectives of cardio-oncology in the field of tumor angiogenesis-targeting tyrosine kinase inhibitor-based therapy.

Bronte G, Bronte E, Novo G, Pernice G, Lo Vullo F, Musso E, Bronte F, Gulotta E, Rizzo S, Rolfo C, Silvestris N, Bazan V, Novo S, Russo A. Bronte G, et al. Among authors: russo a. Expert Opin Drug Saf. 2015 Feb;14(2):253-67. doi: 10.1517/14740338.2015.986092. Epub 2014 Dec 13. Expert Opin Drug Saf. 2015. PMID: 25494575 Review.

2

Nm23-H1 expression does not predict clinical survival in colorectal cancer patients.

Dusonchet L, Corsale S, Migliavacca M, Calò V, Bazan V, Amato A, Cammareri P, Totaro MS, Agnese V, Cascio S, La Rocca G, Sisto PS, Dardanoni G, Valerio MR, Grassi N, Latteri S, Cajozzo M, Buscemi M, Castorina S, Morello V, Tomasino RM, Gebbia N, Russo A. Dusonchet L, et al. Among authors: russo a. Oncol Rep. 2003 Sep-Oct;10(5):1257-63. Oncol Rep. 2003. PMID: 12883690

3

STAT proteins: from normal control of cellular events to tumorigenesis.

Calò V, Migliavacca M, Bazan V, Macaluso M, Buscemi M, Gebbia N, Russo A. Calò V, et al. Among authors: russo a. J Cell Physiol. 2003 Nov;197(2):157-68. doi: 10.1002/jcp.10364. J Cell Physiol. 2003. PMID: 14502555 Review.

4

Heterogeneity within and between primary colorectal carcinomas and matched metastases as revealed by analysis of Ki-ras and p53 mutations.

Albanese I, Scibetta AG, Migliavacca M, Russo A, Bazan V, Tomasino RM, Colomba P, Tagliavia M, La Farina M. Albanese I, et al. Among authors: russo a. Biochem Biophys Res Commun. 2004 Dec 17;325(3):784-91. doi: 10.1016/j.bbrc.2004.10.111. Biochem Biophys Res Commun. 2004. PMID: 15541358 Clinical Trial.

5

Pharmacogenomics in colorectal carcinomas: future perspectives in personalized therapy.

Russo A, Corsale S, Cammareri P, Agnese V, Cascio S, Di Fede G, Macaluso M, Bazan V. Russo A, et al. J Cell Physiol. 2005 Sep;204(3):742-9. doi: 10.1002/jcp.20357. J Cell Physiol. 2005. PMID: 15828025 Review.

6

The TP53 colorectal cancer international collaborative study on the prognostic and predictive significance of p53 mutation: influence of tumor site, type of mutation, and adjuvant treatment.

Russo A, Bazan V, Iacopetta B, Kerr D, Soussi T, Gebbia N; TP53-CRC Collaborative Study Group. Russo A, et al. J Clin Oncol. 2005 Oct 20;23(30):7518-28. doi: 10.1200/JCO.2005.00.471. Epub 2005 Sep 19. J Clin Oncol. 2005. PMID: 16172461 Review.

7

Targeting apoptosis in solid tumors: the role of bortezomib from preclinical to clinical evidence.

Russo A, Fratto ME, Bazan V, Schiró V, Agnese V, Cicero G, Vincenzi B, Tonini G, Santini D. Russo A, et al. Expert Opin Ther Targets. 2007 Dec;11(12):1571-86. doi: 10.1517/14728222.11.12.1571. Expert Opin Ther Targets. 2007. PMID: 18020979 Review.

8

Is BRCA1-5083del19, identified in breast cancer patients of Sicilian origin, a Calabrian founder mutation?

Russo A, Calò V, Bruno L, Schirò V, Agnese V, Cascio S, Foddai E, Fanale D, Rizzo S, Di Gaudio F, Gulotta E, Surmacz E, Di Fede G, Bazan V. Russo A, et al. Breast Cancer Res Treat. 2009 Jan;113(1):67-70. doi: 10.1007/s10549-008-9906-7. Epub 2008 Jan 29. Breast Cancer Res Treat. 2009. PMID: 18228134

9

Hereditary ovarian cancer.

Russo A, Calò V, Bruno L, Rizzo S, Bazan V, Di Fede G. Russo A, et al. Crit Rev Oncol Hematol. 2009 Jan;69(1):28-44. doi: 10.1016/j.critrevonc.2008.06.003. Epub 2008 Jul 24. Crit Rev Oncol Hematol. 2009. PMID: 18656380 Free article. Review.

10

Could starvation minimize chemotherapy-induced toxicities?

Russo A, Rizzo S. Russo A, et al. Expert Opin Ther Targets. 2008 Sep;12(9):1205-7. doi: 10.1517/14728222.12.9.1205. Expert Opin Ther Targets. 2008. PMID: 18694384 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

4,600 results

Search Page

Filters